Boston Scientific (BSX)

Total Liabilities

$20.04B

Quarterly · Period ending: · USD

BSX logo

BSX Total Liabilities

Latest reported$20.04B
BSX Quarterly Total Liabilities ($47.10M → $20.04B)
High-resolution chart · PNG

BSX total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
20,044,000,000
18,247,000,000
19,201,000,000
19,077,000,000
18,906,000,000
17,694,000,000
17,392,000,000
17,122,000,000
16,498,000,000
16,501,000,000
15,606,000,000
14,914,000,000
15,116,000,000
14,783,000,000
14,896,000,000
14,307,000,000
14,938,000,000
15,602,000,000
15,607,000,000
15,415,000,000
15,226,000,000
15,181,000,000
15,451,000,000
15,281,000,000
15,207,000,000
16,309,000,000
16,688,000,000
17,057,000,000
14,884,000,000
14,569,000,000
12,273,000,000
12,090,000,000
11,871,000,000
12,172,000,000
12,030,000,000
11,048,000,000
11,147,000,000
10,890,000,000
11,363,000,000
11,215,000,000
11,618,000,000
11,261,000,000
11,813,000,000
11,805,000,000
10,543,000,000
9,971,000,000
9,987,000,000
10,017,000,000
9,933,000,000
9,801,000,000
10,195,000,000
10,354,000,000
10,393,000,000
10,260,000,000
10,284,000,000
10,070,000,000
10,092,000,000
9,789,000,000
9,937,000,000
9,981,000,000
10,019,000,000
10,701,000,000
10,832,000,000
11,448,000,000
12,126,000,000
12,072,000,000
12,876,000,000
12,638,000,000
12,779,000,000
12,829,000,000
13,965,000,000
14,136,000,000
14,266,000,000
14,955,000,000
16,100,000,000
15,817,000,000
15,463,000,000
15,520,000,000
15,798,000,000
15,736,000,000
15,725,000,000
4,438,000,000
3,914,000,000
4,175,000,000
3,866,000,000
3,429,000,000
4,145,000,000
3,978,000,000
3,728,000,000
2,625,000,000
2,837,000,000
2,628,000,000
2,269,000,000
2,137,000,000
1,983,000,000
1,981,000,000
2,020,000,000
1,913,000,000
1,959,000,000
1,900,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.